Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. intramuscular injection
Show results for
Products
Services
Training
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Intramuscular Injection Articles & Analysis

8 news found

Treatment of Prostatitis - What Forms of Medicines Released?

Treatment of Prostatitis - What Forms of Medicines Released?

Prostatitis is a disease characterized by the presence of inflammation and/or infection localized in the prostate gland. ...

ByProUroCare Medical Inc.


FDA Emerging Technology Program

FDA Emerging Technology Program

Broomfield Colorado 6/16/2022. Aktiv Pharma Group (Aktiv) announced today the acceptance of its novel glass-free, film-based flexible primary drug container (PDC) technology for sterile injectables named ARCH, into the US Food and Drug Administration (FDA) Emerging Technology Program (ETP). The ETP is a collaborative effort which supports the FDA’s mission to facilitate modernization in ...

ByAktiv Pharma Group, Inc


Micron Biomedical Presents at the White House Summit on the Future of COVID-19 Vaccines

Micron Biomedical Presents at the White House Summit on the Future of COVID-19 Vaccines

Simple and/or self-administration delivery technology, such as Micron’s, that doesn’t require intramuscular injection or a cold chain, with no sharps waste, is a critical innovation to making vaccines easier to administer and distribute, expanding access globally. ...

ByMicron Biomedical, Inc.


INOVIO Collaborates with GuardRX and Geneva University Hospitals for Heterologous Booster Clinical Trial of its Ebola DNA Vaccine Candidate, INO-4201

INOVIO Collaborates with GuardRX and Geneva University Hospitals for Heterologous Booster Clinical Trial of its Ebola DNA Vaccine Candidate, INO-4201

The trial will evaluate the safety, tolerability, and immunogenicity of INO-4201 in healthy adult volunteers who previously received a single intramuscular injection of rVSV-ZEBOV (Ervebo). Ervebo is approved by the U.S. ...

ByINOVIO Pharmaceuticals


Virometix Announces Publication of Key Non-Clinical Proof-ofConcept Data in Two High Quality Peer-Reviewed Journals

Virometix Announces Publication of Key Non-Clinical Proof-ofConcept Data in Two High Quality Peer-Reviewed Journals

The second manuscript has been published in “Vaccine” and provides important data validating the potential of V-306 to be administered ‘epicutaneously’ via skin patch delivery, as a method to boost protective immunity to RSV following initial intramuscular injection. Following administration of V-306, the immune response is characterized ...

ByVirometix AG


Medigen and BlueWillow Biologics Partner to Develop Intranasal Vaccine for SARS-CoV-2

Medigen and BlueWillow Biologics Partner to Develop Intranasal Vaccine for SARS-CoV-2

While the majority of COVID-19 vaccines in development today are delivered via intramuscular injection, research has demonstrated that nasal delivery – often the initial site of the infection – can prevent the virus from taking hold in the body. Preclinical research demonstrated that BlueWillow’s nasal vaccine adjuvant combined with ...

ByBlueWillow Biologics


Zeneo® Adrenaline: A New Innovative Formulation

Zeneo® Adrenaline: A New Innovative Formulation

Recent guidelines for anaphylactic shock management state that intramuscular injection of adrenaline should be favored over intravenous injection, as the former offers better cardiovascular tolerance than the latter3. ZENEO® Adrenaline is a pre-filled, needle-free, single-use intramuscular autoinjector. The device is ...

ByCrossject


Royal Government of Bhutan, Merck and Australian Cervical Cancer Foundation partner on vaccination program with GARDASIL(R) for girls and young women of Bhutan

Royal Government of Bhutan, Merck and Australian Cervical Cancer Foundation partner on vaccination program with GARDASIL(R) for girls and young women of Bhutan

Common adverse reactions that were observed among recipients of GARDASIL at a frequency of at least 1.0 percent and greater than placebo were: fever, nausea, dizziness; and injection-site pain, swelling, erythema, pruritus and bruising. Dosage and administration for GARDASIL GARDASIL is a ready-to-use, three-dose, intramuscular vaccine. GARDASIL should be ...

ByCSRwire - Corporate Social Responsibility Newswire

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT